UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000015337
Receipt No. R000017834
Official scientific title of the study Treatment of vocal fold scar with KP-100LI: phase I/II clinical trial
Date of disclosure of the study information 2014/10/03
Last modified on 2017/07/24 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Treatment of vocal fold scar with KP-100LI: phase I/II clinical trial
Title of the study (Brief title) KP-100LI for vocal scar
Region
Japan

Condition
Condition Vocal fold scar, sulcus
Classification by specialty
Oto-rhino-laryngology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To explore safty aspect and vocal outcome by local application of KP-100LI to vocal fold scar and sulcus
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase Phase I,II

Assessment
Primary outcomes Safty aspect for KP-100LI
Key secondary outcomes Therapeutic effect in VHI-10, Jitter, MPT, GRBAS, NMWA

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -but assessor(s) are blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Transoral application of KP-100LI to the vocal fold
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
65 years-old >=
Gender Male and Female
Key inclusion criteria Diagnosis of vocal fold scar or suclus by stroboscopic exmaination
No orgnic or neurologic disorder on the vocal fold
More than 11 scor of VHI-10
Key exclusion criteria Airway disease caused by burn
History of malignant diseases
Pregnant woman
Severe systemic diseases
Target sample size 18

Research contact person
Name of lead principal investigator Shigeru Hirano
Organization Kyoto University Hospital
Division name Otolaryngology
Address Sakyo-ku, Kyoto 606-8507
TEL 075-751-3731
Email hirano@ent.kuhp.kyoto-u.ac.jp

Public contact
Name of contact person Shigeru Hirano
Organization Kyoto University Hospital
Division name Otolaryngology
Address Sakyo-ku, Kyoto 606-8507
TEL 075-751-3731
Homepage URL
Email hirano@ent.kuhp.kyoto-u.ac.jp

Sponsor
Institute Kyoto University Hospital
Institute of Biomedical Research and Innovation
Institute
Department

Funding Source
Organization Ministry of Health and Welfare
Organization
Division
Category of Funding Organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 10 Month 03 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 10 Month 03 Day
Anticipated trial start date
2014 Year 10 Month 03 Day
Last follow-up date
2016 Year 06 Month 16 Day
Date of closure to data entry
2016 Year 11 Month 04 Day
Date trial data considered complete
2016 Year 11 Month 04 Day
Date analysis concluded
2017 Year 03 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 10 Month 03 Day
Last modified on
2017 Year 07 Month 24 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017834